Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danhong Injection in Acute Ischemic Stroke
NCT02152280Phase 4Unknown
- Start
- Mar 2014
- Primary completion
- Dec 2015
- Modality
- Botanical drug
01
Overview
Phase 4, randomised, double-blind trial of danhong injection in ischemic stroke (2 arms). Primary endpoint: Percentage of patients with modified Rankin Scale 0-2 grades at 90 days. Status: unknown.
02
Drugs
danhong injection
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02152280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02152280.